Clari Vest Asset Management LLC Denali Therapeutics Inc. Transaction History

Clari Vest Asset Management LLC

$1 Billion
Q3 2024

A detailed history of Clari Vest Asset Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 22,964 shares of DNLI stock, worth $396,129. This represents 0.07% of its overall portfolio holdings.

Number of Shares

22,964

Previous 22,964 -0.0%

Holding current value

$396,129

Previous $533,000 25.33%

% of portfolio

0.07%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$14.96 - $23.22 $370,768 - $575,484	-24,784 Reduced 51.91%	22,964 $533,000
Q1 2024 May 06, 2024	BUY	$15.83 - $23.35 $119,801 - $176,712	7,568 Added 18.84%	47,748 $979,000
Q4 2023 Feb 13, 2024	SELL	$16.2 - $23.18 $44,080 - $63,072	-2,721 Reduced 6.34%	40,180 $862,000
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $783 - $1,146	38 Added 0.09%	42,901 $885,000
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $149,661 - $211,075	-6,404 Reduced 13.0%	42,863 $1.26 Million
Q1 2023 May 08, 2023	BUY	$21.91 - $32.67 $854 - $1,274	39 Added 0.08%	49,267 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$26.28 - $33.92 $3,994 - $5,155	-152 Reduced 0.31%	49,228 $1.37 Million
Q3 2022 Nov 10, 2022	SELL	$25.97 - $38.53 $136,550 - $202,590	-5,258 Reduced 9.62%	49,380 $1.51 Million
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $229,680 - $387,090	-11,000 Reduced 16.76%	54,638 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $248,214 - $320,656	-5,828 Reduced 8.15%	65,638 $2.93 Million
Q3 2021 Nov 08, 2021	SELL	$48.48 - $78.23 $183,205 - $295,631	-3,779 Reduced 5.02%	71,466 $3.61 Million
Q2 2021 Aug 09, 2021	BUY	$50.3 - $78.44 $2.92 Million - $4.55 Million	58,039 Added 337.32%	75,245 $5.9 Million
Q1 2021 May 13, 2021	BUY	$53.8 - $81.53 $25,447 - $38,563	473 Added 2.83%	17,206 $982,000
Q4 2020 Feb 09, 2021	SELL	$36.89 - $93.56 $839,763 - $2.13 Million	-22,764 Reduced 57.63%	16,733 $1.4 Million
Q3 2020 Nov 09, 2020	BUY	$23.13 - $38.84 $188,694 - $316,856	8,158 Added 26.03%	39,497 $1.41 Million
Q2 2020 Aug 12, 2020	BUY	$16.01 - $28.82 $501,737 - $903,189	31,339 New	31,339 $757,000

Others Institutions Holding DNLI

# of Institutions

248

Shares Held

135M

Call Options Held

148K

Put Options Held

15.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Account

Clari Vest Asset Management LLC Denali Therapeutics Inc. Transaction History